Alliance Global Partners raised the firm’s price target on Myomo (MYO) to $6.75 from $6 and keeps a Buy rating on the shares after the company reported Q4 results that were ahead of the firm’s expectations given strong unit growth for the MyoPro orthotic arm brace. Following earnings, the firm cites higher revenue forecasts for its increased price target
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MYO: